Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
325.42
+5.17 (1.61%)
Oct 20, 2026, 4:00 PM EDT - Market closed
Krystal Biotech Employees
Krystal Biotech had 295 employees as of December 31, 2025. The number of employees increased by 20 or 7.27% compared to the previous year. That makes Krystal Biotech the 23,990th largest employer in the world and 3,078th in the United States.
Employees
295
Change (1Y)
20
Growth (1Y)
7.27%
Revenue / Employee
$1,493,166
Profits / Employee
$818,522
Market Cap
9.63B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 295 | 20 | 7.27% | 295 | 0 |
| Dec 31, 2024 | 275 | 46 | 20.09% | 275 | 0 |
| Dec 31, 2023 | 229 | 19 | 9.05% | 229 | 0 |
| Dec 31, 2022 | 210 | 91 | 76.47% | 210 | 0 |
| Dec 31, 2021 | 119 | 44 | 58.67% | 119 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Caris Life Sciences | 1,846 |
| Axsome Therapeutics | 1,346 |
| Twist Bioscience | 979 |
| Madrigal Pharmaceuticals | 915 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
KRYS News
- 5 days ago - Krystal Biotech price target raised to $416 from $386 at Citi - TheFly
- 5 days ago - Krystal Biotech provides clinical data for KB113 program - TheFly
- 5 days ago - Krystal Biotech Announces Positive Clinical Data for New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression in Patients with Gorlin Syndrome - GlobeNewsWire
- 26 days ago - Krystal Biotech resumed with a Buy at Goldman Sachs - TheFly
- 4 weeks ago - Krystal Biotech price target raised to $400 from $392 at BofA - TheFly
- 5 weeks ago - Krystal Biotech Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 6 weeks ago - Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Krystal Biotech initiated with an Outperform at RBC Capital - TheFly